Search Results - "Goddard, B A"

Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study by AIELLO BOWLES, Erin J, WELLMAN, Robert, HABEL, Laurel A, ULCICKAS YOOD, Marianne, MCCARTY, Catherine, MAGID, David J, WAGNER, Edward H, SPENCER FEIGELSON, Heather, ONITILO, Adedayo A, FREEDMAN, Andrew N, DELATE, Thomas, ALLEN, Larry A, NEKHLYUDOV, Larissa, GODDARD, Katrina A. B, DAVIS, Robert L

“…Clinical trials demonstrated that women treated for breast cancer with anthracycline or trastuzumab are at increased risk for heart failure and/or…”
Get full text

Systematic review of the predictive effect of MSI status in colorectal cancer patients undergoing 5FU-based chemotherapy by Webber, Elizabeth M, Kauffman, Tia L, O'Connor, Elizabeth, Goddard, Katrina A B

“…We systematically reviewed the evidence for the interaction of microsatellite instability status (MSI) and treatment with 5FU in colorectal cancer to determine…”
Get full text

Improving reporting standards for polygenic scores in risk prediction studies by Wand, Hannah, Lambert, Samuel A., Tamburro, Cecelia, Iacocca, Michael A., O’Sullivan, Jack W., Sillari, Catherine, Kullo, Iftikhar J., Rowley, Robb, Dron, Jacqueline S., Brockman, Deanna, Venner, Eric, McCarthy, Mark I., Antoniou, Antonis C., Easton, Douglas F., Hegele, Robert A., Khera, Amit V., Chatterjee, Nilanjan, Kooperberg, Charles, Edwards, Karen, Vlessis, Katherine, Kinnear, Kim, Danesh, John N., Parkinson, Helen, Ramos, Erin M., Roberts, Megan C., Ormond, Kelly E., Khoury, Muin J., Janssens, A. Cecile J. W., Goddard, Katrina A. B., Kraft, Peter, MacArthur, Jaqueline A. L., Inouye, Michael, Wojcik, Genevieve L.

“…Polygenic risk scores (PRSs), which often aggregate results from genome-wide association studies, can bridge the gap between initial discovery efforts and…”
Get full text

Assessment of willingness to pay for expanded carrier screening among women and couples undergoing preconception carrier screening by Clarke, Elizabeth V, Schneider, Jennifer L, Lynch, Frances, Kauffman, Tia L, Leo, Michael C, Rosales, Ana G, Dickerson, John F, Shuster, Elizabeth, Wilfond, Benjamin S, Goddard, Katrina A B

“…Expanded carrier screening can provide risk information for numerous conditions. Understanding how individuals undergoing preconception expanded carrier…”
Get full text

Retrospective assessment of barriers and access to genetic services for hereditary cancer syndromes in an integrated health care delivery system by Muessig, Kristin R, Zepp, Jamilyn M, Keast, Erin, Shuster, Elizabeth E, Reyes, Ana A, Arnold, Briana, Ingphakorn, Chalinya, Gilmore, Marian J, Kauffman, Tia L, Hunter, Jessica Ezzell, Knerr, Sarah, Feigelson, Heather S, Goddard, Katrina A B

“…A critical step in access to genetic testing for hereditary cancer syndromes is referral for genetic counseling to assess personal and family risk. Individuals…”
Get full text

Literacy-adapted, electronic family history assessment for genetics referral in primary care: patient user insights from qualitative interviews by Mittendorf, Kathleen F, Lewis, Hannah S, Duenas, Devan M, Eubanks, Donna J, Gilmore, Marian J, Goddard, Katrina A B, Joseph, Galen, Kauffman, Tia L, Kraft, Stephanie A, Lindberg, Nangel M, Reyes, Ana A, Shuster, Elizabeth, Syngal, Sapna, Ukaegbu, Chinedu, Zepp, Jamilyn M, Wilfond, Benjamin S, Porter, Kathryn M

“…Risk assessment for hereditary cancer syndromes is recommended in primary care, but family history is rarely collected in enough detail to facilitate risk…”
Get full text

“Is It Worth Knowing?” Focus Group Participants’ Perceived Utility of Genomic Preconception Carrier Screening by Schneider, Jennifer L., Goddard, Katrina A. B., Davis, James, Wilfond, Benjamin, Kauffman, Tia L., Reiss, Jacob A., Gilmore, Marian, Himes, Patricia, Lynch, Frances L., Leo, Michael C., McMullen, Carmit

“…As genome sequencing technology advances, research is needed to guide decision-making about what results can or should be offered to patients in different…”
Get full text

Patient and provider perspectives on adherence to and care coordination of lynch syndrome surveillance recommendations: findings from qualitative interviews by Schneider, Jennifer L, Goddard, Katrina A B, Muessig, Kristin R, Davis, James V, Rope, Alan F, Hunter, Jessica E, Peterson, Susan K, Acheson, Louise S, Syngal, Sapna, Wiesner, Georgia L, Reiss, Jacob A

“…Patients with a genetic variant associated with Lynch syndrome (LS) are recommended to undergo frequent and repeated cancer surveillance activities to minimize…”
Get full text

Recommended care and care adherence following a diagnosis of Lynch syndrome: a mixed-methods study by Mittendorf, Kathleen F, Hunter, Jessica Ezzell, Schneider, Jennifer L, Shuster, Elizabeth, Rope, Alan F, Zepp, Jamilyn, Gilmore, Marian J, Muessig, Kristin R, Davis, James V, Kauffman, Tia L, Bergen, Kellene M, Wiesner, Georgia L, Acheson, Louise S, Peterson, Susan K, Syngal, Sapna, Reiss, Jacob A, Goddard, Katrina A B

“…Lynch syndrome (LS) is the most common hereditary colorectal cancer (CRC) syndrome. This study assesses trends in diagnosis of LS and adherence to recommended…”
Get full text

Does KRAS testing in metastatic colorectal cancer impact overall survival? A comparative effectiveness study in a population-based sample by Feigelson, Heather Spencer, Zeng, Chan, Pawloski, Pamala A, Onitilo, Adedayo A, Richards, C Sue, Johnson, Monique A, Kauffman, Tia L, Webster, Jennifer, Nyirenda, Carsie, Alexander, Gwen L, Hwang, Clara, Cross, Deanna, McCarty, Catherine A, Davis, Robert L, Schwarzkopf, Denise, Williams, Andrew E, Honda, Stacey, Daida, Yihe, Kushi, Lawrence H, Delate, Thomas, Goddard, Katrina A B

“…Epidermal growth factor receptor (EGFR) inhibitors are approved for treating metastatic colorectal cancer (CRC); KRAS mutation testing is recommended prior to…”
Get full text

Barriers in Identification and Referral to Genetic Counseling for Familial Cancer Risk: The Perspective of Genetic Service Providers by Rolnick, Sharon J., Rahm, Alanna K., Jackson, Jody M., Nekhlyudov, Larissa, Goddard, Katrina A. B., Field, Terry, McCarty, Catherine, Nakasato, Cynthia, Roblin, Douglas, Anderson, Christopher P., Valdez, Rodolfo

“…The purpose of this study was to obtain genetic counselors’ perspectives about the identification of appropriate patients and barriers to referral of high-risk…”
Get full text

Evaluating genomic tests from bench to bedside: a practical framework by Lin, Jennifer S, Thompson, Matthew, Goddard, Katrina A B, Piper, Margaret A, Heneghan, Carl, Whitlock, Evelyn P

“…The development of genomic tests is one of the most significant technological advances in medical testing in recent decades. As these tests become increasingly…”
Get full text

Establishing the Medical Actionability of Genomic Variants by Goddard, Katrina A.B, Lee, Kristy, Buchanan, Adam H, Powell, Bradford C, Hunter, Jessica Ezzell

“…Actionability is an important concept in medicine that does not have a well-accepted standard definition, nor is there a general consensus on how to establish…”
Get full text

Time Costs for Genetic Counseling in Preconception Carrier Screening with Genome Sequencing by Lynch, Frances L., Himes, Patricia, Gilmore, Marian J., Morris, Elissa M., Schneider, Jennifer L., Kauffman, Tia L., Shuster, Elizabeth, Reiss, Jacob A., Dickerson, John F., Leo, Michael C., Davis, James V., McMullen, Carmit K., Wilfond, Benjamin S., Goddard, Katrina A.B.

“…Advances in technology and the promise of personalized health care are driving greater use of genome sequencing (GS) for a variety of clinical scenarios. As…”
Get full text

Longitudinal adherence to breast cancer surveillance following cancer genetic testing in an integrated health care system by Knerr, Sarah, Guo, Boya, Wernli, Karen J., Mittendorf, Kathleen F., Feigelson, Heather Spencer, Gilmore, Marian J., Jarvik, Gail P., Kauffman, Tia L., Keast, Erin, Liles, Elizabeth G., Lynch, Frances L., Muessig, Kristin R., Okuyama, Sonia, Veenstra, David L., Zepp, Jamilyn M., Wilfond, Benjamin S., Devine, Beth, Goddard, Katrina A. B.

“…Purpose Screening with mammography and breast magnetic resonance imaging (MRI) is an important risk management strategy for individuals with inherited…”
Get full text

The Long Behavioral Tail of the COVID-19 Pandemic-A Cancer Control Perspective by Klein, William M P, Dwyer, Laura A, Goddard, Katrina A B

Get more information

Integrating stakeholder feedback in translational genomics research: an ethnographic analysis of a study protocol’s evolution by Kraft, Stephanie A., McMullen, Carmit, Lindberg, Nangel M., Bui, David, Shipman, Kelly, Anderson, Katherine, Joseph, Galen, Duenas, Devan M., Porter, Kathryn M., Kauffman, Tia L., Koomas, Alyssa, Ransom, Chelese L., Jackson, Paige, Goddard, Katrina A. B., Wilfond, Benjamin S., Lee, Sandra Soo-Jin

“…Purpose This study describes challenges faced while incorporating sometimes conflicting stakeholder feedback into study design and development of…”
Get full text

Risk management actions following genetic testing in the Cancer Health Assessments Reaching Many (CHARM) Study: A prospective cohort study by Guo, Boya, Knerr, Sarah, Kauffman, Tia L., Mittendorf, Kathleen F., Keast, Erin, Gilmore, Marian J., Feigelson, Heather Spencer, Lynch, Frances L., Muessig, Kristin R., Okuyama, Sonia, Zepp, Jamilyn M., Veenstra, David L., Hsu, Li, Phipps, Amanda I., Lindström, Sara, Leo, Michael C., Goddard, Katrina A. B., Wilfond, Benjamin S., Devine, Beth, Allen, Jake, Amendola, Laura M., Anderson, Katherine P., Angelo, Frank, Arnold, Briana L., Bellcross, Cecelia, Bendelow, Tiffany, Biesecker, Barbara B., Breslin, Kristin D., Bulkley, Joanna E., Booker, Kristina F., Caruncho, Mikaella, Davis, James V., Deutsch, Sonia, Dorschner, Michael O., Duenas, Devan M., Eubanks, Donna J., Freed, Amanda S., Gilmore, Marian J., Greaney, Clay, Gruß, Inga, Guerra, Claudia, Holup, Joan, Hunter, Jessica Ezzell, Ingphakorn, Chalinya L., Jackson, Paige, Jarvik, Gail P., Jenkins, Charisma L., Joseph, Galen, Karliner, Leah S., Koomas, Alyssa H., Kraft, Stephanie A., Lee, Mi H., Lee, Robin, Lee, Sandra Soo‐Jin, Lewis, Hannah S., Liles, Elizabeth G., Lindberg, Nangel M., McMullen, Carmit K., Medina, Elizabeth, Muessig, Kristin R., Okuyama, Sonia, Peterson, C. Samuel, Paolucci, Angela R., Perez, Rosse Rodriguez, Porter, Kathryn M., Ransom, Chelese L., Reyes, Ana, Riddle, Leslie S., Robinson, Sperry, Rolf, Bradley A., Rope, Alan F., Schield, Emily, Schneider, Jennifer L., Shipman, Kelly J., Shirts, Brian H, Shuster, Elizabeth, Syngal, Sapna, Torgrimson‐Ojerio, Britta N., Ukaegbu, Chinedu, Vandermeer, Meredith L., Varga, Alexandra M., Veenstra, David L., Whitebirch, W. Chris, White, Larissa Lee

“…Background Genetic testing can identify cancer risk early, enabling prevention and early detection. We describe use of risk management interventions following…”
Get full text

Promoting equity, inclusion, and efficiency: A team science approach to the development of authorship guidelines for a multi-disciplinary research team by Lewis, Hannah, Biesecker, Barbara, Lee, Sandra Soo-Jin, Anderson, Katherine, Joseph, Galen, Jenkins, Charisma L, Bulkley, Joanna E, Leo, Michael C, Goddard, Katrina A B, Wilfond, Benjamin S

“…Large research teams and consortia present challenges for authorship. The number of disciplines involved in the research can further complicate approaches to…”
Get full text

Expert and lay perspectives on burden, risk, tolerability, and acceptability of clinical interventions for genetic disorders by Paquin, Ryan S., Mittendorf, Kathleen F., Lewis, Megan A., Hunter, Jessica Ezzell, Lee, Kristy, Berg, Jonathan S., Williams, Marc S., Goddard, Katrina A. B.

“…Purpose The Clinical Genome Resource (ClinGen) Actionability Working Group (AWG) developed a semiquantitative scoring metric to rate clinical actionability of…”
Get full text